Cerenome (CNSY) Gross Profit Growth (3y) (2014 - 2018)
Powered by 
Analysis
Cerenome (CNSY) Gross Profit Growth (3y) (2014 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 9.20% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 10.09% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 77.42% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 28.75% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 45.27% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 59.77% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 80.79% |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | -4.49% |
| Jun 30, 2018 | -54.48% |
| Mar 31, 2018 | -20.72% |
| Dec 31, 2017 | -69.80% |
| Sep 30, 2017 | -28.27% |
| Jun 30, 2017 | 15.74% |
| Mar 31, 2017 | -30.16% |
| Dec 31, 2016 | -30.91% |
| Sep 30, 2016 | -45.16% |
| Jun 30, 2016 | -12.23% |
| Mar 31, 2016 | 6.40% |
| Dec 31, 2015 | -33.10% |
| Sep 30, 2015 | -24.40% |
| Jun 30, 2015 | -29.69% |
| Mar 31, 2015 | -21.40% |
| Dec 31, 2014 | -2.38% |
| Sep 30, 2014 | -46.65% |
| Jun 30, 2014 | -49.37% |
| Mar 31, 2014 | 5.47% |